Serge Rivest Selected Research

Melatonin

2/2023	Author Correction: Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis.
1/2023	Melatonin and vitamin D, two sides of the same coin, better to land on its edge to improve multiple sclerosis.
1/2023	Inhibiting nighttime melatonin and boosting cortisol increase patrolling monocytes, phagocytosis, and myelination in a murine model of multiple sclerosis.
1/2022	Reduced melatonin levels may facilitate glioblastoma initiation in the subventricular zone.
1/2022	PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Serge Rivest Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 05/2008
18	Inflammation (Inflammations) 01/2023 - 09/2002
13	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 07/2002
13	Cognitive Dysfunction 01/2022 - 05/2008
12	Multiple Sclerosis 02/2023 - 10/2005
11	Infections 12/2023 - 04/2002
7	Amyloid Plaque 01/2022 - 02/2006
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2005
7	Neuroinflammatory Diseases 01/2022 - 12/2006
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 07/2002
6	Encephalitis (Encephalitis, Rasmussen) 11/2020 - 03/2007
5	Wounds and Injuries (Trauma) 01/2020 - 10/2003
5	Brain Injuries (Brain Injury) 06/2016 - 12/2006
4	Memory Disorders (Memory Loss) 10/2022 - 04/2009
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2011 - 02/2004
4	Peripheral Nerve Injuries 08/2011 - 11/2007
3	Brain Ischemia (Cerebral Ischemia) 01/2018 - 02/2009
2	Seizures (Absence Seizure) 05/2021 - 07/2004
2	Nervous System Diseases (Neurological Disorders) 01/2020 - 01/2016
2	Ischemia 01/2018 - 07/2013
2	Hyperalgesia 05/2014 - 08/2011
2	Stroke (Strokes) 10/2013 - 02/2009
2	Infarction (Infarctions) 10/2013 - 02/2009
2	Disease Progression 03/2012 - 07/2002
2	Neoplasms (Cancer) 09/2008 - 06/2004
2	Spinal Cord Injuries (Spinal Cord Injury) 07/2007 - 11/2003
2	Endotoxemia 04/2003 - 09/2002
1	Vitamin D Deficiency 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Nemaline Myopathies (Nemaline Myopathy) 01/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2021
1	Microcephaly 02/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Leukemia 11/2018
1	Multiple Myeloma 11/2018
1	Metabolic Diseases (Metabolic Disease) 11/2018
1	Thrombotic Stroke 01/2018

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 06/2023 - 05/2005
17	Amyloid (Amyloid Fibrils)IBA 12/2023 - 04/2011
12	CytokinesIBA 01/2018 - 04/2002
9	Amyloid beta-PeptidesIBA 01/2020 - 05/2008
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 07/2002
8	Peptides (Polypeptides)IBA 12/2023 - 04/2009
7	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2013 - 11/2004
6	Macrophage Colony-Stimulating FactorIBA 11/2020 - 04/2009
5	MelatoninIBA 02/2023 - 01/2022
5	Neuroprotective AgentsIBA 04/2021 - 10/2007
5	Toll-Like Receptor 2IBA 05/2011 - 07/2002
4	CuprizoneIBA 01/2021 - 04/2015
4	GlucocorticoidsIBA 10/2007 - 09/2002
3	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2023 - 01/2023
3	CCR2 ReceptorsIBA 01/2018 - 04/2011
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2016 - 07/2002
3	LigandsIBA 05/2015 - 11/2007
3	Superoxide Dismutase-1IBA 11/2011 - 02/2004
3	NF-kappa B (NF-kB)IBA 10/2007 - 07/2002
2	EnzymesIBA 01/2022 - 01/2009
2	Acetylmuramyl-Alanyl-IsoglutamineIBA 01/2022 - 07/2020
2	Therapeutic UsesIBA 01/2021 - 07/2020
2	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 11/2020 - 01/2020
2	ChemokinesIBA 01/2018 - 07/2013
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2016 - 04/2016
2	Interleukin-10 (Interleukin 10)IBA 02/2015 - 02/2009
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2015 - 09/2012
2	LipopolysaccharidesIBA 05/2014 - 09/2002
2	CX3C Chemokine Receptor 1IBA 07/2013 - 01/2012
2	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 10/2003
2	Interleukin-1 (Interleukin 1)IBA 08/2011 - 06/2009
2	Immunologic Factors (Immunomodulators)IBA 02/2009 - 09/2008
2	Messenger RNA (mRNA)IBA 01/2009 - 04/2002
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2007 - 01/2006
2	Thymidine KinaseIBA 10/2007 - 02/2006
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2007 - 04/2002
2	Interleukin-12 (IL 12)IBA 08/2007 - 04/2003
2	Matrix Metalloproteinases (MMPs)IBA 10/2005 - 11/2003
1	Immune Checkpoint InhibitorsIBA 06/2023
1	NucleotidesIBA 06/2023
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	Phosphotransferases (Kinase)IBA 10/2022
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	ParvalbuminsIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 05/2021
1	nebulinIBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 01/2020
1	purinoceptor P2Y6IBA 01/2020
1	Versicans (Versican)IBA 01/2018
1	ferric chlorideIBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2022 - 03/2007
3	Injections 01/2022 - 02/2004
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2018 - 12/2013
2	Immunomodulation 07/2020 - 07/2013
2	Hematopoietic Stem Cell Transplantation 10/2011 - 06/2004
2	Immunotherapy 10/2009 - 09/2008
1	Phototherapy (Light Therapy) 01/2023
1	Axotomy 01/2020